Ricci, Costantino; Franceschini, Tania; Giunchi, Francesca; Grillini, Marco; Ambrosi, Francesca; Massari, Francesco; Mollica, Veronica; Colecchia, Maurizio; Fiorentino, Michelangelo, Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia in Situ, and Germ Cell Tumors of the Testis, «AMERICAN JOURNAL OF CLINICAL PATHOLOGY», 2021, 157, pp. 1 - 1 [articolo]
Rizzo A.; Mollica V.; Santoni M.; Ricci A.D.; Rosellini M.; Marchetti A.; Montironi R.; Ardizzoni A.; Massari F., Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials, «EUROPEAN UROLOGY FOCUS», 2021, 1077, pp. 1 - 8 [articolo]
Rizzo, Alessandro; Mollica, Veronica; Giunchi, Francesca; Dall'Olio, Filippo Gustavo; Rosellini, Matteo; Marchetti, Andrea; Franceschini, Tania; Schiavina, Riccardo; Brunocilla, Eugenio; Fiorentino, Michelangelo; Ardizzoni, Andrea; Massari, Francesco, Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience, «PATHOLOGY RESEARCH AND PRACTICE», 2021, 220, Article number: 153410, pp. 1 - 5 [articolo]
Zong Y.; Montironi R.; Massari F.; Jiang Z.; Lopez-Beltran A.; Wheeler T.M.; Scarpelli M.; Santoni M.; Cimadamore A.; Cheng L., Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives, «EUROPEAN UROLOGY FOCUS», 2021, 7, pp. 955 - 963 [articolo]
Santoni M.; Massari F.; Montironi R.; Battelli N., Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages, «BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER», 2021, 1876, Article number: 188547, pp. 188547 - 188551 [articolo]
Aurilio G.; Santoni M.; Massari F.; Cimadamore A.; Rizzo A.; Mollica V.; Verri E.; Battelli N.; Montironi R., Metabolomic profiling in renal cell carcinoma patients: News and views, «CANCERS», 2021, 13, Article number: 5229, pp. 1 - 11 [articolo]Open Access
Rizzo A.; Santoni M.; Mollica V.; Fiorentino M.; Brandi G.; Massari F., Microbiota and prostate cancer, «SEMINARS IN CANCER BIOLOGY», 2021, 1044, pp. 1 - 8 [articolo]
Montironi R.; Cheng L.; Cimadamore A.; Mazzucchelli R.; Scarpelli M.; Santoni M.; Massari F.; Lopez-Beltran A., Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups?, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1530 - 1540 [articolo]Open Access
Santoni M.; Cimadamore A.; Massari F.; Sorgentoni G.; Cheng L.; Lopez-Beltran A.; Battelli N.; Montironi R., Narrative review: Predicting future molecular and clinical profiles of prostate cancer in the United States, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1562 - 1568 [articolo]Open Access
Aurilio G.; Cimadamore A.; Lopez-Beltran A.; Scarpelli M.; Massari F.; Verri E.; Cheng L.; Santoni M.; Montironi R., Narrative review: Update on immunotherapy and pathological features in patients with bladder cancer, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1521 - 1529 [articolo]Open Access
de Velasco G.; Ruiz-Granados A.; Reig O.; Massari F.; Climent Duran M.A.; Verzoni E.; Graham J.; Llarena R.; De Tursi M.; Donskov F.; Iglesias C.; Pandha H.S.; Garcia del Muro X.; Procopio G.; Oudard S.; Castellano D.; Albiges L., Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib, «BJU INTERNATIONAL», 2021, 128, pp. 254 - 261 [articolo]
Rizzo A.; Santoni M.; Mollica V.; Logullo F.; Rosellini M.; Marchetti A.; Faloppi L.; Battelli N.; Massari F., Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2021, 17, pp. 1455 - 1466 [articolo]
Mollica, Veronica; Rizzo, Alessandro; Tassinari, Elisa; Giunchi, Francesca; Schiavina, Riccardo; Fiorentino, Michelangelo; Brunocilla, Eugenio; Ardizzoni, Andrea; Massari, Francesco, Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study, «ANTI-CANCER DRUGS», 2021, 32, pp. 74 - 81 [articolo]
Basso U.; Facchinetti A.; Rossi E.; Maruzzo M.; Conteduca V.; Aieta M.; Massari F.; Fraccon A.P.; Mucciarini C.; Sava T.; Santoni M.; Pegoraro C.; Durante E.; Nicodemo M.; Perin A.; Bearz A.; Gatti C.; Fiduccia P.; Diminutto A.; Barile C.; De Giorgi U.; Zamarchi R.; Zagonel V., Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial, «THE ONCOLOGIST», 2021, 26, pp. 740 - 750 [articolo]
